99 related articles for article (PubMed ID: 7560447)
1. Infrequent expression of protein p53 in epidermotropic variants of cutaneous T-cell lymphoma.
de Misa RF; Azaña JM; Harto A; Bellas C; Ledo A
J Dermatol; 1995 Jul; 22(7):524-6. PubMed ID: 7560447
[TBL] [Abstract][Full Text] [Related]
2. p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas.
van Haselen CW; Vermeer MH; Toonstra J; van der Putte SC; Mulder PG; van Vloten WA; Willemze R
J Cutan Pathol; 1997 Sep; 24(8):462-7. PubMed ID: 9331891
[TBL] [Abstract][Full Text] [Related]
3. p53 oncoprotein expression in cutaneous lymphoproliferations.
Beylot-Barry M; Vergier B; DeMascarel A; Beylot C; Merlio JP
Arch Dermatol; 1995 Sep; 131(9):1019-24. PubMed ID: 7661603
[TBL] [Abstract][Full Text] [Related]
4. p53 protein expression in cutaneous T-cell lymphomas.
Lauritzen AF; Vejlsgaard GL; Hou-Jensen K; Ralfkiaer E
Br J Dermatol; 1995 Jul; 133(1):32-6. PubMed ID: 7669637
[TBL] [Abstract][Full Text] [Related]
5. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
6. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.
Li G; Chooback L; Wolfe JT; Rook AH; Felix CA; Lessin SR; Salhany KE
J Invest Dermatol; 1998 May; 110(5):767-70. PubMed ID: 9579543
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.
Wei T; Biskup E; Gjerdrum LM; Niazi O; Ødum N; Gniadecki R
Oncotarget; 2016 Jul; 7(30):48391-48400. PubMed ID: 27351221
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
11. p53 immunoreactivity is uncommon in primary cutaneous lymphoma.
McGregor JM; Dublin EA; Levison DA; MacDonald DM; Smith NP; Whittaker S
Br J Dermatol; 1995 Mar; 132(3):353-8. PubMed ID: 7718450
[TBL] [Abstract][Full Text] [Related]
12. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
Tensen CP; Vermeer MH; van der Stoop PM; van Beek P; Scheper RJ; Boorsma DM; Willemze R
J Invest Dermatol; 1998 Aug; 111(2):222-6. PubMed ID: 9699721
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
14. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.
Blom A; Beylot-Barry M; D'Incan M; Laroche L
J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
17. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
18. Intraepidermal localization of the clone in cutaneous T-cell lymphoma.
Bagot M; Wechsler J; Lescs MC; Revuz J; Farcet JP; Gaulard P
J Am Acad Dermatol; 1992 Oct; 27(4):589-93. PubMed ID: 1357011
[TBL] [Abstract][Full Text] [Related]
19. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
